Central venous catheters and complications in cancer patients Case report
Article Sidebar
Main Article Content
Abstract
Vascular access has great importance in the treatment of patients submitted to prolonged chemotherapy. We report two patients with early and late complications related to the presence of a central venous catheter. The first case presents right subclavian vein thrombosis as a consequence of thrombosis of the port. In the second case, the improper catheter tip set close to tricuspid valve ring generated cardiac arrhythmia felt as palpitations and referred by the patient as lowering the quality of life. In both those cases good cooperation between cardiologist and oncologist determined the diagnosis and implementation of appropriate proceeding that brought significant improvement.
Downloads
Article Details
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright: © Medical Education sp. z o.o. This is an Open Access article distributed under the terms of the Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). License (https://creativecommons.org/licenses/by-nc/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Address reprint requests to: Medical Education, Marcin Kuźma (marcin.kuzma@mededu.pl)
References
2. Cadman A., Lawrance J.A., Fitzsimmons L., Spencer-Shaw A., Swindell R.: To clot or not to clot? That is the question in central venous catheters. Clin. Radiol. 2004; 59(4): 349-355.
3. Lee A.Y., Levine M.N., Butler G. et al.: Incidence, risk factors, and outcomes of catheter-related thrombosis in adult patients with cancer. J. Clin. Oncol. 2006; 24(9): 1404-1408.
4. Verso M., Agnelli G., Kamphuisen P.W. et al.: Risk factors for upper limb deep vein thrombosis associated with the use of central vein catheter in cancer patients. Intern. Emerg. Med. 2008; 3(2): 117-122.
5. Lee A.Y., Kamphuisen P.W.: Epidemiology and prevention of catheter-related thrombosis in patients with cancer. J. Thromb. Haemost. 2012; 10(8): 1491-9.
6. Kahn S.R., Lim W., Dunn A.S. et al.: Prevention of VTE in Nonsurgical Patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. CHEST 2012; 141(2_suppl): e195S-e226S.
7. Heaton D.C., Han D.Y., Inder A.: Minidose (1 mg) warfarin as prophylaxis for central vein catheter thrombosis. Intern. Med. J. 2002; 32: 84-88.
8. Couban S., Goodyear M. , Burnell M. et al.: Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheterassociated thrombosis in patients with cancer. J. Clin. Oncol. 2005; 23: 4063-4069.
9. Karthaus M., Kretzschmar A., Kroning H. et al.: Dalteparin for prevention of catheter-related complications in cancer patients with central venous catheters: final results of a double-blind, placebo-controlled phase III trial. Ann. Oncol. 2006; 17: 289-296.
10. Verso M., Agnelli G., Bertoglio S. et al.: Enoxaparin for the prevention of venous-thromboembolism associated with central vein catheter: a double-blind, placebo-controlled, randomized study in cancer patients. J. Clin. Oncol. 2005; 23: 4057-4062.
11. Young A.M., Bilingham L.J., Begum G. et al.: Warfarin thromboprophylaxis in cancer patients with central venous catheters (WARP): an open-label randomised trial. Lancet 2009; 373: 567-574.
12. Lyman G.H., Khorana A.A., Falanga A. et al.: American Society of Clinical Oncology guideline: recommendations for venous thromboembolism prophylaxis and treatment in patients with cancer. J. Clin. Oncol. 2007; 25: 5490-5505.
13. Monreal M., Falgá C., Valdés M. et al.: Fatal pulmonary embolism and fatal bleeding in cancer patients with venous thromboembolism: findings from the RIETE registry. J. Thromb. Haemost. 2006; 4: 1950-1956.
14. NCCN Clinical Practice Guidelines in Oncology: Venous Thromboembolism Disease 9V. 1.2012). National Comprehensive Cancer Network Web site. Online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp#vte.